Cargando…

Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma

Detalles Bibliográficos
Autores principales: Cho, Min-Seok, Kim, Jae Yong, Jung, Seung-Yeon, Ahn, Seo-Yeon, Song, Ga young, Yang, Deok-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234245/
https://www.ncbi.nlm.nih.gov/pubmed/28090494
http://dx.doi.org/10.5045/br.2016.51.4.285
_version_ 1782494968191909888
author Cho, Min-Seok
Kim, Jae Yong
Jung, Seung-Yeon
Ahn, Seo-Yeon
Song, Ga young
Yang, Deok-Hwan
author_facet Cho, Min-Seok
Kim, Jae Yong
Jung, Seung-Yeon
Ahn, Seo-Yeon
Song, Ga young
Yang, Deok-Hwan
author_sort Cho, Min-Seok
collection PubMed
description
format Online
Article
Text
id pubmed-5234245
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-52342452017-01-15 Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma Cho, Min-Seok Kim, Jae Yong Jung, Seung-Yeon Ahn, Seo-Yeon Song, Ga young Yang, Deok-Hwan Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016-12 2016-12-23 /pmc/articles/PMC5234245/ /pubmed/28090494 http://dx.doi.org/10.5045/br.2016.51.4.285 Text en © 2016 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Cho, Min-Seok
Kim, Jae Yong
Jung, Seung-Yeon
Ahn, Seo-Yeon
Song, Ga young
Yang, Deok-Hwan
Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
title Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
title_full Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
title_fullStr Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
title_full_unstemmed Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
title_short Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
title_sort salvage chemotherapy with r-bad (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary cns lymphoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234245/
https://www.ncbi.nlm.nih.gov/pubmed/28090494
http://dx.doi.org/10.5045/br.2016.51.4.285
work_keys_str_mv AT chominseok salvagechemotherapywithrbadrituximabbendamustinecytarabineanddexamethasoneforthetreatmentofrelapsedprimarycnslymphoma
AT kimjaeyong salvagechemotherapywithrbadrituximabbendamustinecytarabineanddexamethasoneforthetreatmentofrelapsedprimarycnslymphoma
AT jungseungyeon salvagechemotherapywithrbadrituximabbendamustinecytarabineanddexamethasoneforthetreatmentofrelapsedprimarycnslymphoma
AT ahnseoyeon salvagechemotherapywithrbadrituximabbendamustinecytarabineanddexamethasoneforthetreatmentofrelapsedprimarycnslymphoma
AT songgayoung salvagechemotherapywithrbadrituximabbendamustinecytarabineanddexamethasoneforthetreatmentofrelapsedprimarycnslymphoma
AT yangdeokhwan salvagechemotherapywithrbadrituximabbendamustinecytarabineanddexamethasoneforthetreatmentofrelapsedprimarycnslymphoma